TD Securities Has Lowered Expectations for Nutrien (NYSE:NTR) Stock Price

Nutrien (NYSE:NTR) had its price objective dropped by stock analysts at TD Securities from $63.00 to $61.00 in a research note issued to investors on Tuesday,BayStreet.CA reports. The brokerage currently has a “buy” rating on the stock. TD Securities’ price target suggests a potential upside of 30.31% from the stock’s current price.

Other analysts also recently issued reports about the company. BMO Capital Markets lowered their price target on Nutrien from $80.00 to $75.00 and set an “outperform” rating for the company in a report on Friday, August 9th. Royal Bank of Canada reiterated an “outperform” rating and set a $60.00 target price on shares of Nutrien in a report on Friday, September 20th. Mizuho decreased their price target on Nutrien from $55.00 to $52.00 and set a “neutral” rating for the company in a report on Thursday, August 8th. Hsbc Global Res lowered shares of Nutrien from a “hold” rating to a “moderate sell” rating in a research note on Friday, August 2nd. Finally, Barclays decreased their target price on shares of Nutrien from $68.00 to $55.00 and set an “overweight” rating for the company in a research note on Friday, August 16th. Three equities research analysts have rated the stock with a sell rating, six have given a hold rating and ten have assigned a buy rating to the stock. According to MarketBeat, Nutrien presently has a consensus rating of “Hold” and a consensus target price of $60.33.

Nutrien Stock Performance

Nutrien stock opened at $46.81 on Tuesday. The company has a debt-to-equity ratio of 0.38, a current ratio of 1.27 and a quick ratio of 0.82. Nutrien has a 12 month low of $44.65 and a 12 month high of $60.87. The company has a market cap of $23.12 billion, a price-to-earnings ratio of 31.81, a price-to-earnings-growth ratio of 1.61 and a beta of 0.82. The stock’s 50-day moving average is $48.00 and its 200-day moving average is $50.53.

Nutrien (NYSE:NTR) last announced its quarterly earnings results on Wednesday, November 6th. The company reported $0.39 earnings per share for the quarter, missing analysts’ consensus estimates of $0.43 by ($0.04). Nutrien had a net margin of 2.79% and a return on equity of 6.99%. The business had revenue of $5.35 billion for the quarter, compared to analyst estimates of $5.26 billion. During the same period last year, the firm earned $0.35 earnings per share. The company’s quarterly revenue was down 5.0% on a year-over-year basis. Equities analysts anticipate that Nutrien will post 3.65 earnings per share for the current year.

Institutional Investors Weigh In On Nutrien

Several institutional investors and hedge funds have recently made changes to their positions in NTR. Central Pacific Bank Trust Division bought a new stake in Nutrien during the third quarter valued at $28,000. Family Firm Inc. bought a new stake in shares of Nutrien during the 2nd quarter valued at about $32,000. Trust Co. of Vermont raised its stake in Nutrien by 50.0% during the second quarter. Trust Co. of Vermont now owns 900 shares of the company’s stock worth $46,000 after acquiring an additional 300 shares during the period. Covestor Ltd lifted its holdings in Nutrien by 33.3% in the first quarter. Covestor Ltd now owns 932 shares of the company’s stock worth $50,000 after acquiring an additional 233 shares during the last quarter. Finally, Andra AP fonden acquired a new position in Nutrien in the second quarter valued at approximately $51,000. 63.10% of the stock is owned by institutional investors and hedge funds.

About Nutrien

Nutrien Ltd. provides crop inputs and services. The company operates through four segments: Retail, Potash, Nitrogen, and Phosphate. The Retail segment distributes crop nutrients, crop protection products, seeds, and merchandise products. The Potash segment provides granular and standard potash products.